Table 1.
Clinicopathologic characteristics of cases with the initial pathology diagnosis other than SGC
| Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | |
|---|---|---|---|---|---|
| Site | L upper and lower | L upper | L upper and lower | R upper | R lower |
| Initial diagnosis at other clinic | Blepharitis, keratoconjunctivitis | Suspected malignant tumor | Blepharitis | Suspected malignant tumor | Suspected malignant tumor |
| Metastasis | + | − | − | − | − |
| Pagetoid spread | + | − | + | − | + |
| Ki67 index | 64.8 | 46.6 | 40.6 | 73.2 | 60.2 |
| Differentiation | Poor | Good | Good | Moderate | Moderate |
| Mitosis | >5/HPF | 0–1/HPF | 0–1/HPF | >5/HPF | 2–8/HPF |
| Initial pathological diagnosis | SCC | BCC | Bowen’s disease | SCC | SCC |
| Immunostaining | AR (+) | AR (+) | AR (−) | AR (+) | AR (+) |
| ADP (+) | ADP (+) | ADP (+) | ADP (+) | ADP (+) |
SGC, sebaceous gland carcinoma; M, male; F, female; R, right; L, left; HPF, high power field; SCC, squamous cell carcinoma; BCC, basal cell carcinoma; AR, androgen receptor; ADP, adipophilin.